Foad Alzoughool

753 total citations
26 papers, 537 citations indexed

About

Foad Alzoughool is a scholar working on Infectious Diseases, Molecular Biology and Physiology. According to data from OpenAlex, Foad Alzoughool has authored 26 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Foad Alzoughool's work include COVID-19 Clinical Research Studies (8 papers), Adipose Tissue and Metabolism (8 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Foad Alzoughool is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Adipose Tissue and Metabolism (8 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Foad Alzoughool collaborates with scholars based in Jordan, United Arab Emirates and Canada. Foad Alzoughool's co-authors include Manar Atoum, Lo’ai Alanagreh, Huda Al Hourani, Suhad Abumweis, Mohammad Borhan Al‐Zghoul, Michael H. Gollob, Jean Champagne, Jeff S. Healey, Chris Simpson and Shubhayan Sanatani and has published in prestigious journals such as Heliyon, Pharmaceuticals and Genes.

In The Last Decade

Foad Alzoughool

25 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Foad Alzoughool Jordan 10 206 134 83 62 61 26 537
Filippo Scialò Italy 13 337 1.6× 154 1.1× 55 0.7× 139 2.2× 86 1.4× 36 753
Jorge Hernández‐Bello Mexico 14 249 1.2× 126 0.9× 49 0.6× 31 0.5× 28 0.5× 65 641
Denise Asafu‐Adjei United States 8 82 0.4× 326 2.4× 91 1.1× 28 0.5× 71 1.2× 12 859
Michael P. Morran United States 10 143 0.7× 137 1.0× 38 0.5× 67 1.1× 52 0.9× 18 749
Yihao Liu China 15 216 1.0× 143 1.1× 97 1.2× 45 0.7× 20 0.3× 50 788
Kajal Rawat India 9 173 0.8× 146 1.1× 66 0.8× 31 0.5× 42 0.7× 21 480
Stephany Beyerstedt Brazil 4 332 1.6× 107 0.8× 44 0.5× 162 2.6× 28 0.5× 11 593
Duomeng Yang China 11 102 0.5× 148 1.1× 30 0.4× 32 0.5× 31 0.5× 26 450
Mengzhen Dong China 9 169 0.8× 101 0.8× 35 0.4× 80 1.3× 32 0.5× 21 542
Xiuqin Hong China 10 95 0.5× 76 0.6× 45 0.5× 41 0.7× 23 0.4× 29 363

Countries citing papers authored by Foad Alzoughool

Since Specialization
Citations

This map shows the geographic impact of Foad Alzoughool's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Foad Alzoughool with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Foad Alzoughool more than expected).

Fields of papers citing papers by Foad Alzoughool

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Foad Alzoughool. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Foad Alzoughool. The network helps show where Foad Alzoughool may publish in the future.

Co-authorship network of co-authors of Foad Alzoughool

This figure shows the co-authorship network connecting the top 25 collaborators of Foad Alzoughool. A scholar is included among the top collaborators of Foad Alzoughool based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Foad Alzoughool. Foad Alzoughool is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Alzoughool, Foad, et al.. (2024). Evaluation of adropin level and insulin resistance in non-alcoholic fatty liver patients: a meta-analysis of studies.. PubMed. 28(21). 4507–4514. 1 indexed citations
3.
Alzoughool, Foad, et al.. (2022). Impact of Sustained Exogenous Irisin Myokine Administration on Muscle and Myocyte Integrity in Sprague Dawley Rats. Metabolites. 12(10). 939–939. 3 indexed citations
4.
Alzoughool, Foad, Suhad Abumweis, Lo’ai Alanagreh, & Manar Atoum. (2022). Associations of pre-existing cardiovascular morbidity with severity and the fatality rate in COVID-19 patients: a systematic review and meta-analysis. Osong Public Health and Research Perspectives. 13(1). 37–50. 5 indexed citations
5.
Abumweis, Suhad, et al.. (2022). Association of obesity with COVID-19 diseases severity and mortality: A meta-analysis of studies. Obesity Medicine. 33. 100431–100431. 13 indexed citations
6.
7.
Khattab, Ahmed, et al.. (2022). Effects of Citrus limon leaf extract on blood glucose and lipid profile in alloxan monohydrate-induced diabetic rats. Gazzetta Medica Italiana Archivio per le Scienze Mediche. 180(11). 1 indexed citations
8.
Alzoughool, Foad, et al.. (2022). The Role of Interventional Irisin on Heart Molecular Physiology. Pharmaceuticals. 15(7). 863–863. 5 indexed citations
9.
Alzoughool, Foad & Mohammad Borhan Al‐Zghoul. (2021). Optimal therapeutic adropin dose intervention in mice and rat animal models: A systematic review. Veterinary World. 14(6). 1426–1429. 5 indexed citations
10.
Hourani, Huda Al, et al.. (2021). Screening for non-invasive risk factors of type 2 diabetes in overweight and obese schoolchildren. Endocrinología Diabetes y Nutrición. 68(8). 527–533. 2 indexed citations
11.
Al‐Awaida, Wajdy, Samer Swedan, Refat M. Nimer, et al.. (2021). Correlates of SARS-CoV-2 Variants on Deaths, Case Incidence and Case Fatality Ratio among the Continents for the Period of 1 December 2020 to 15 March 2021. Genes. 12(7). 1061–1061. 8 indexed citations
12.
13.
Alanagreh, Lo’ai, Foad Alzoughool, & Manar Atoum. (2020). Risk of using hydroxychloroquine as a treatment of COVID-19. International Journal of Risk & Safety in Medicine. 31(3). 111–116. 24 indexed citations
14.
Alzoughool, Foad & Lo’ai Alanagreh. (2020). Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19. International Journal of Risk & Safety in Medicine. 31(2). 47–51. 24 indexed citations
15.
Alzoughool, Foad, Lo’ai Alanagreh, Suhad Abumweis, & Manar Atoum. (2020). Cerebrovascular comorbidity, high blood levels of C-reactive protein and D-dimer are associated with disease outcomes in COVID-19 patients. Clinical Hemorheology and Microcirculation. 77(3). 311–322. 20 indexed citations
16.
Alzoughool, Foad, et al.. (2020). The optimal therapeutic irisin dose intervention in animal model: A systematic review. Veterinary World. 13(10). 2191–2196. 9 indexed citations
17.
Alzoughool, Foad, et al.. (2020). The rs2236609 Polymorphism Is Related to Increased Risk Susceptibility of Atrial Fibrillation. Public Health Genomics. 23(1-2). 54–58. 1 indexed citations
18.
Alanagreh, Lo’ai, Foad Alzoughool, & Manar Atoum. (2020). The Human Coronavirus Disease COVID-19: Its Origin, Characteristics, and Insights into Potential Drugs and Its Mechanisms. Pathogens. 9(5). 331–331. 209 indexed citations
19.
Alzoughool, Foad, et al.. (2019). Irisin, leptin and adiponectin levels are reduced significantly during fasting. Mediterranean Journal of Nutrition and Metabolism. 12(4). 389–396. 11 indexed citations
20.
Adler, Arnon, et al.. (2014). First Report of a Large Duplication of the KCNQ1 Gene in a Patient With Long QT Syndrome. Canadian Journal of Cardiology. 30(10). 1249.e5–1249.e7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Filippo Scialò Breakdown of academic impact, for papers by Jorge Hernández‐Bello Breakdown of academic impact, for papers by Denise Asafu‐Adjei Breakdown of academic impact, for papers by Michael P. Morran Breakdown of academic impact, for papers by Yihao Liu Breakdown of academic impact, for papers by Kajal Rawat Breakdown of academic impact, for papers by Stephany Beyerstedt Breakdown of academic impact, for papers by Duomeng Yang Breakdown of academic impact, for papers by Mengzhen Dong Breakdown of academic impact, for papers by Xiuqin Hong
Rankless by CCL
2026